BIRC5 and cancer: Another dominant negative mutant (GST-tagged dominant-negative Survivin protein (dNSurR9-C84A) constructed by mutation of Cys84 to Ala in the extreme C-terminal region of the BIR domain of Survivin completely abrogated Survivin’s ability to inhibit apoptosis in cancer cell lines [148].